# EDGAR Filing Document

**Accession Number:** 0000816956
**File Stem:** 0001127602-25-016753
**Filing Date:** 2025-6
**Character Count:** 11901
**Document Hash:** 2f6736501a36681b894b91535df89623
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-25-016753.hdr.sgml**: 20250604

**ACCESSION NUMBER**: 0001127602-25-016753

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250602

**FILED AS OF DATE**: 20250604

**DATE AS OF CHANGE**: 20250604

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Aronson Martha Goldberg
- **CENTRAL INDEX KEY:** 0001429832

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39218
- **FILM NUMBER:** 251024200

**MAIL ADDRESS:**
- **STREET 1:** 40 WEST HIGHLAND PARK DRIVE NE
- **CITY:** HUTCHINSON
- **STATE:** MN
- **ZIP:** 55350
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CONMED Corp
- **CENTRAL INDEX KEY:** 0000816956
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 160977505
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773
- **BUSINESS PHONE:** 727-214-2974

**MAIL ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONMED CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

CONMED CORPORATION
LIMITED POWER OF ATTORNEY FOR SECTION 16 AND RULE 144 FILINGS AND LOCK-UP
AGREEMENTS
Know all by these presents, that the undersigned hereby constitutes and
appoints each of the following attorneys of CONMED Corporation (the "Company"):
Hollie Foust, EVP, General Counsel and Corporate Secretary; Thomas Fistek,
Chief Counsel, Assistant Corporate Secretary; Megan Zielonko, Director,
Counsel; Amber Straub, Director, Counsel; Lawrence Jordan III, Director,
Counsel; Johonna Pelletier, Treasurer and Vice President Tax; Kim Lockwood,
Senior Director Financial Reporting; Julie Hall, Manager Legal Operations;
Celeste Templeton, Manager Compensation; and Michele Caiola, Paralegal, as the
undersigned's true and lawful attorney-in-fact to: 1.	execute for and on behalf
of the undersigned, in the undersigned's capacity as an officer or director or
both of the Company, Forms 3, 4 and 5 (and any amendments thereto) in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended and the rules and regulations promulgated thereunder (the "Exchange
Act"), and any Form 144 under the Securities Act of 1933, as amended, as well
as any Lock-Up Agreements; 2.	do and perform any and all acts for and on behalf
of the undersigned which may be necessary or desirable to complete and execute
any such Form 3, 4, 5, Form 144 Notice or Lock-Up Agreements, complete and
execute any amendments thereto, and timely file such form, with all amendments,
supplements and exhibits thereto, with the Securities and Exchange Commission
and any securities exchange or similar authority; 3.	seek or obtain, as the
undersigned's representative and on the undersigned's behalf, information on
transactions in the Company's securities from any third party, including but
not limited to brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to each of the undersigned's attorneys-in-fact appointed by this
Limited Power of Attorney and approves and ratifies any such release of
information; and 4.	take any other action in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by or for, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Limited Power of Attorney shall be in such
form and shall contain such information and disclosure as such attorney-in-fact
may approve in such attorney-in-fact's discretion. The undersigned hereby
grants to each such attorney-in-fact, acting individually, full power and
authority to do and perform any and every act and thing whatsoever required,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact's substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Limited Power of Attorney and the rights and
powers herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request and on the behalf
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with, or any liability for the failure
to ,. comply with, any provision of Section 16 of the Exchange Act. This
Limited Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, 5 and 144 and Lock-Up
Agreements with respect to the undersigned's holdings of and transactions in
securities issued by the Company, unless earlier revoked by the undersigned in
a signed writing delivered to each of the foregoing attorneys-in-fact. IN
WITNESS WHEREOF, the undersigned has executed this Limited Power of Attorney as
of this 20th May 2025. Martha Goldberg Aronson Signed and acknowledged:
ACKNOWLEDGEMENT STATE OF Florida COUNTY OF Pinellas On May 20, 2025 before me,
the undersigned, personally appeared Martha Goldberg Aronson personally known
to me or proved to me on the basis of satisfactory evidence to be the
individual whose name is subscribed to the within instrument and acknowledged
to me that he/she executed the same in his/her capacity, and that by his/her
signature on the instrument, the individual, or the person upon behalf of which
the individual acted, executed the instrument. Jacqueline A Sinclair Notary
Public: State of Florida Comm: HH 413419 Expires: Jul 14, 2027 Notary Public ?
State of Florida

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Aronson Martha Goldberg<br><sub>(Last) (First) (Middle)</sub><br>C/O CONMED CORPORATION<br>11311 CONCEPT BOULEVARD<br><sub>(Street)</sub><br>LARGO, FL 33773<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CONMED Corp [ CNMD ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-06-03 |  | M |  | 479 | A | $0 | 12391 | D |  |
| Common Stock |  |  |  |  |  |  |  | 2000 | I | by IRA |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Options To Purchase Common Stock | $55.38 | 2025-06-02 |  | A |  | 8061 |  | 2026-06-02<sup>(1)</sup> | 2035-06-02 | Common Stock | 8061 | $0 | 8061 | D |  |
| RSUs (Restricted Stock Units) | $0 | 2025-06-02 |  | A |  | 668 |  | 2026-06-02<sup>(2)</sup> | 2035-06-02 | Common Stock | 668 | $0 | 668 | D |  |
| RSUs (Restricted Stock Units) | $0 | 2025-06-03 |  | M |  |  | 479 | 2025-06-03<sup>(3)</sup> | 2034-06-03 | Common Stock | 479 | $0 | 0 | D |  |

---

### Footnotes:

(1) The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.

(2) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

(3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

**Signature:** /s/ Thomas Fistek for Martha Goldberg Aronson by Power of Attorney  
**Date:** 2025-06-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**